Epilepsy in Legius syndrome: Coincidence or causation?
American Journal of Medical Genetics Part A · 2024-06 · 194 (6)
DOI: 10.1002/ajmg.a.63547 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 24.01.2024. Verfasst von Adalbeis Medina Lemus und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Epilepsy, Cafe-au-Lait Spots. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds de Recherche du Québec - Santé.
Abstract (Originalsprache)
Legius syndrome is a rare genetic disorder, caused by heterozygous SPRED1 pathogenic variants, which shares phenotypic features with neurofibromatosis type 1 (NF1). Both conditions typically involve café‐au‐lait macules, axillary freckling, and macrocephaly; however, patients with NF1 are also at risk for tumors, such as optic nerve gliomas and neurofibromas. Seizure risk is known to be elevated in NF1, but there has been little study of this aspect of Legius syndrome. The reported epilepsy incidence is 3.3%–5%, well above the general population incidence of ~0.5%–1%, but the few reports in the literature have very little data regarding epilepsy phenotype. We identified two unrelated individuals, both with Legius syndrome and epilepsy, and performed thorough phenotyping. One individual's mother also had Legius syndrome and now‐resolved childhood epilepsy, as well as reports of more distant relatives who also had multiple café‐au‐lait macules and seizures. Both probands had experienced childhood‐onset focal seizures, with normal brain MRI. In one patient, EEG later showed apparently generalized epileptiform abnormalities. Based on the data from this small case series and literature review, seizure risk is increased in people with Legius syndrome, but the epilepsy prognosis appears to be generally good, with patients having either self‐limited or pharmacoresponsive courses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neurology, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
- Division of Neurology, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, British Columbia, Canada.
- Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
- Department of Neurology and Neurosurgery, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
ORCID-Profile: Kenneth A Myers
Förderung
- Fonds de Recherche du Québec - Santé
Zitieren
APA
Medina Lemus, A., Boelman, C., & Myers, K. A. (2024). Epilepsy in Legius syndrome: Coincidence or causation?. American Journal of Medical Genetics Part A, 194(6). https://doi.org/10.1002/ajmg.a.63547
Vancouver
Medina Lemus A, Boelman C, Myers KA. Epilepsy in Legius syndrome: Coincidence or causation?. American Journal of Medical Genetics Part A. 2024;194(6). doi:10.1002/ajmg.a.63547
BibTeX
@article{MedinaLemus2024,
author = {Medina Lemus, Adalbeis and Boelman, Cyrus and Myers, Kenneth A},
title = {Epilepsy in Legius syndrome: Coincidence or causation?},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
volume = {194},
number = {6},
doi = {10.1002/ajmg.a.63547}
}
EUVIMED